FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Info Collection on Device Classification Inquiries

Federal Register notice: FDA sends to OMB an information collection extension entitled 513(g) Request for Information for device classification inquir...

Human Drugs

FDA Priority Review for Keytruda Plus Lenvima

FDA gives priority review to two applications from Merck and Eisai for the combination of Keytruda and Lenvima to treat some cases of advanced renal c...

Federal Register

Pharmacy Compounding Advisory Panel Meets 6/9

Federal Register notice: FDA announces a 6/9 Pharmacy Compounding Advisory Committee meeting to discuss four bulk drug substances.

Biologics

Check Aluminum Levels in 13 Vaccines: Researcher

A researcher from a British university says only three of 13 childrens vaccines tested contained the aluminum level stated in the labeling.

Human Drugs

SCOTUS Should Hear Janssen Preemption Case: Column

American Tort Reform Association president Tiger Joyce says the Supreme Court should hear Janssens appeal of a Philadelphia court decision that contra...

Human Drugs

Dont Block e-Labeling of Rx Drugs: Bipartisan House Members

A bipartisan group of 20 House members urge the Appropriations Committee not to block an FDA proposal to allow digital sharing of labeling information...

Medical Devices

Medo 510(k) for AI Thyroid Scan Assessment

FDA clears a Medo 510(k) for its Medo-Thyroid, an artificial intelligence device intended to simplify thyroid ultrasound scanning workflow.

Medical Devices

Accreditation Scheme for Conformity Assessment Webinar

FDA announces a 5/20 Webinar to share information and answer questions about its medical device Accreditation Scheme for Conformity Assessment Pilot.

Biologics

Rejuvenate Stem Cell Center Cautioned on Umbilical Stem Cells

CBER says Rejuvenate Stem Cell Center is marketing umbilical stem cells for a variety of diseases and conditions without an NDA or BLA.

Human Drugs

10 Observations in Hospira FDA-483

FDA releases the FDA-483 with 10 observations issued following an inspection six months ago at Hospiras sterile drug manufacturing facility in McPhers...